Dr Luis Tavernelli

  • Research Associate (Parasitology)

Publications

List by: Type | Date

Jump to: 2022 | 2019
Number of items: 3.

2022

Pezza, A. et al. (2022) Essential bromodomain TcBDF2 as a drug target against Chagas disease. ACS Infectious Diseases, 8(5), pp. 1062-1074. (doi: 10.1021/acsinfecdis.2c00057) (PMID:35482332)

2019

Alonso, V. L., Tavernelli, L. E., Pezza, A., Cribb, P., Ritagliati, C. and Serra, E. (2019) Aim for the readers! Bromodomains as new targets against Chagas’ disease. Current Medicinal Chemistry, 26(36), pp. 6544-6563. (doi: 10.2174/0929867325666181031132007) (PMID:30378479)

Tavernelli, L. E., Motta, M. C. M., Gonçalves, C. S., da Silva, M. S., Elias, M. C., Alonso, V. L., Serra, E. and Cribb, P. (2019) Overexpression of Trypanosoma cruzi High Mobility Group B protein (TcHMGB) alters the nuclear structure, impairs cytokinesis and reduces the parasite infectivity. Scientific Reports, 9, 192. (doi: 10.1038/s41598-018-36718-0) (PMID:30655631) (PMCID:PMC6336821)

This list was generated on Fri May 17 13:40:52 2024 BST.
Jump to: Articles
Number of items: 3.

Articles

Pezza, A. et al. (2022) Essential bromodomain TcBDF2 as a drug target against Chagas disease. ACS Infectious Diseases, 8(5), pp. 1062-1074. (doi: 10.1021/acsinfecdis.2c00057) (PMID:35482332)

Alonso, V. L., Tavernelli, L. E., Pezza, A., Cribb, P., Ritagliati, C. and Serra, E. (2019) Aim for the readers! Bromodomains as new targets against Chagas’ disease. Current Medicinal Chemistry, 26(36), pp. 6544-6563. (doi: 10.2174/0929867325666181031132007) (PMID:30378479)

Tavernelli, L. E., Motta, M. C. M., Gonçalves, C. S., da Silva, M. S., Elias, M. C., Alonso, V. L., Serra, E. and Cribb, P. (2019) Overexpression of Trypanosoma cruzi High Mobility Group B protein (TcHMGB) alters the nuclear structure, impairs cytokinesis and reduces the parasite infectivity. Scientific Reports, 9, 192. (doi: 10.1038/s41598-018-36718-0) (PMID:30655631) (PMCID:PMC6336821)

This list was generated on Fri May 17 13:40:52 2024 BST.